MAR 24, 2022
Comprehensive Ophthalmology, Uveitis
0.5 General AMA PRA Category 1 Credits™
Drs. Jessica Shantha and Brian Do discuss local therapy options for uveitis, including sub-Tenon's and intravitreal corticosteroid approaches, patient selection and contraindications, and side effects of local treatment.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Release: March 24, 2025; expires March 24, 2025.
Planner/Faculty: Dr. Sridhar receives consulting fees from Allergan and Alcon.
Faculty: Dr. Do receives consulting or lecture fees from Alimera Sciences, Allergan, and Bausch & Lomb. Dr. Shantha reports no relevant financial disclosures.
Review Panel: The following reviewers report no financial disclosures: Jeffrey D. Henderer, MD; Danah Albreiki, MBBS; Ashiyani Nariani, MD, MPH; Mazeyar Saboori, MD; Annie Moreau, MD; and Allison Umfress, MD
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the local management of uveitis and how these standards impact patient care decisions.
Audience: This activity is intended for comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this internet enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.